Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05920850 · ClinicalTrials.gov registry record · NA

The SHARED, Project, Lung Cancer Screening for African American Men (AAM)

A NA study of Lung Cancer Screening, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT05920850 is a NA study of Lung Cancer Screening that has completed, run by University of Illinois at Chicago. The registered enrollment target is 37 participants, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05920850, a NA study of Lung Cancer Screening, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)

Conditions Studied

Interventions

  • OTHER Educational Video about LDCT lung cancer screening
  • OTHER A culturally tailored shared decision-making tool
  • OTHER Flip chart
  • OTHER Navigation support

Study Locations (1)

Illinois

  • University of Illinois - Chicago

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2023-07-14
Est. Completion 2024-01-31
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05920850

The ClinicalTrials.gov registry entry for NCT05920850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (93% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 4 interventions - of which Educational Video about LDCT lung cancer screening is the first listed.

NCT05920850 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05920850 about?

NCT05920850 is a clinical study titled "The SHARED, Project, Lung Cancer Screening for African American Men (AAM)". This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)

What is the current status of trial NCT05920850?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2023-07-14. Estimated completion is 2024-01-31.

What conditions does trial NCT05920850 study?

This clinical trial studies the following conditions: Lung Cancer Screening.

What interventions are being tested in trial NCT05920850?

The interventions under investigation include: Educational Video about LDCT lung cancer screening (OTHER), A culturally tailored shared decision-making tool (OTHER), Flip chart (OTHER), Navigation support (OTHER).

Who is sponsoring clinical trial NCT05920850?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05920850 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.